This inventor holds 2 USPTO granted patents and 1 published patent application, plus 11 CIPO patents and 7 EPO patents. Top assignee: Alcon Research, Ltd.. Active years: 2012-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012-2015
Title: Innovations by Ryan Desousa
Introduction
Ryan Desousa is an accomplished inventor based in Fort Worth, Texas. He has made significant contributions to the field of biocides and medical devices. With a total of two patents to his name, Desousa's work focuses on enhancing the safety and efficacy of cationic biocides.
Latest Patents
Desousa's latest patents include innovative methods for controlling the interaction of cationic biocides using labile anionic polyelectrolytes. These methods aim to inhibit the uptake of cationic biocides into medical devices, such as contact lenses and implants. His inventions also describe methods for stabilizing emulsions containing cationic biocides, utilizing polymers like galactomannan and polyvinyl alcohol to reduce harmful effects while maintaining biocidal activity. Another notable patent involves polyquaternary ammonium polymers that contain polyalkylene oxide groups, providing a versatile approach to biocide formulation.
Career Highlights
Throughout his career, Desousa has worked with prominent companies in the field, including Alcon Research, Ltd. and Alcon, Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical technology.
Collaborations
Desousa has collaborated with notable colleagues, including Nissanke L Dassanayake and Howard Allen Ketelson. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise.
Conclusion
Ryan Desousa's contributions to the field of biocides and medical devices highlight his innovative spirit and dedication to improving safety in healthcare. His patents reflect a commitment to advancing technology for better patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
